Latest stories

  • in

    SC dismisses plea seeking CBI probe against 10 pharma cos for selling Remdesivir, Favipiravir without valid license

    SC dismisses plea seeking CBI probe against 10 pharma cos for selling Remdesivir, Favipiravir without valid license

    New Delhi: The Supreme Court on Monday dismissed a plea alleging use of drugs Remdesivir and Favipiravir, without approval, for treatment of Covid-19 and also seeking CBI probe against ten Indian pharmaceutical firms for selling these medicines allegedly in the absence of valid licenses. A bench, headed by Chief Justice of India D.Y. Chandrachud and […] More